83 FR 58683 - Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders

DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration

Federal Register Volume 83, Issue 224 (November 20, 2018)

Page Range		58683-58685
FR Document		2018-25278

FMCSA announces its decision to renew exemptions for 12 individuals from the requirement in the Federal Motor Carrier Safety Regulations (FMCSRs) that interstate commercial motor vehicle (CMV) drivers have ``no established medical history or clinical diagnosis of epilepsy or any other condition which is likely to cause loss of consciousness or any loss of ability to control a CMV.'' The exemptions enable these individuals who have had one or more seizures and are taking anti-seizure medication to continue to operate CMVs in interstate commerce.

Federal Register, Volume 83 Issue 224 (Tuesday, November 20, 2018)

[Federal Register Volume 83, Number 224 (Tuesday, November 20, 2018)]
[Notices]
[Pages 58683-58685]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-25278]


-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2014-0213; FMCSA-2015-0323]


Qualification of Drivers; Exemption Applications; Epilepsy and 
Seizure Disorders

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice of renewal of exemptions; request for comments.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces its decision to renew exemptions for 12 
individuals from the requirement in the Federal Motor Carrier Safety 
Regulations (FMCSRs) that interstate commercial motor vehicle (CMV) 
drivers have ``no established medical history or clinical diagnosis of 
epilepsy or any other condition which is likely to cause loss of 
consciousness or any loss of ability to control a CMV.'' The exemptions 
enable these individuals who have had one or more seizures and are 
taking anti-seizure medication to continue to operate CMVs in 
interstate commerce.

DATES: Each group of renewed exemptions were applicable on the dates 
stated in the discussions below and will expire on the dates stated in 
the discussions below. Comments must be received on or before December 
20, 2018.

ADDRESSES: You may submit comments identified by the Federal Docket 
Management System (FDMS) Docket No. FMCSA-2014-0213; FMCSA-2015-0323 
using any of the following methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the online instructions for submitting 
comments.
     Mail: Docket Management Facility; U.S. Department of 
Transportation, 1200 New Jersey Avenue SE, West Building Ground Floor, 
Room W12-140, Washington, DC 20590-0001.
     Hand Delivery: West Building Ground Floor, Room W12-140, 
1200 New Jersey Avenue SE, Washington, DC, between 9 a.m. and 5 p.m., 
ET, Monday through Friday, except Federal Holidays.
     Fax: 1-202-493-2251.
    To avoid duplication, please use only one of these four methods. 
See the ``Public Participation'' portion of the SUPPLEMENTARY 
INFORMATION section for instructions on submitting comments.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, 
Medical Programs Division, 202-366-4001, [email protected], FMCSA, 
Department of Transportation, 1200 New Jersey Avenue SE, Room W64-224, 
Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m., 
ET, Monday through Friday, except Federal holidays. If you have 
questions regarding viewing or submitting material to the docket, 
contact Docket Services, telephone (202) 366-9826.

SUPPLEMENTARY INFORMATION:

I. Public Participation

A. Submitting Comments

    If you submit a comment, please include the docket number for this 
notice (Docket Nos. FMCSA-2015-0323; FMCSA-2014-0213), indicate the 
specific section of this document to which each comment applies, and 
provide a reason for each suggestion or recommendation. You may submit 
your comments and material online or by fax, mail, or hand delivery, 
but please use only one of these means. FMCSA recommends that you 
include your name and a mailing address, an email address, or a phone 
number in the body of your document so that FMCSA can contact you if 
there are questions regarding your submission.
    To submit your comment online, go to http://www.regulations.gov, 
put the

[[Page 58684]]

docket numbers, FMCSA-2014-0213; FMCSA-2015-0323, in the keyword box, 
and click ``Search.'' When the new screen appears, click on the 
``Comment Now!'' button and type your comment into the text box on the 
following screen. Choose whether you are submitting your comment as an 
individual or on behalf of a third party and then submit.
    If you submit your comments by mail or hand delivery, submit them 
in an unbound format, no larger than 8\1/2\ by 11 inches, suitable for 
copying and electronic filing. If you submit comments by mail and would 
like to know that they reached the facility, please enclose a stamped, 
self-addressed postcard or envelope.
    FMCSA will consider all comments and material received during the 
comment period.

B. Viewing Documents and Comments

    To view comments, as well as any documents mentioned in this notice 
as being available in the docket, go to http://www.regulations.gov. 
Insert the docket numbers, FMCSA-2014-0213; FMCSA-2015-0323, in the 
keyword box, and click ``Search.'' Next, click the ``Open Docket 
Folder'' button and choose the document to review. If you do not have 
access to the internet, you may view the docket online by visiting the 
Docket Management Facility in Room W12-140 on the ground floor of the 
DOT West Building, 1200 New Jersey Avenue SE, Washington, DC 20590, 
between 9 a.m. and 5 p.m., ET, Monday through Friday, except Federal 
holidays.

C. Privacy Act

    In accordance with 5 U.S.C. 553(c), DOT solicits comments from the 
public to better inform its rulemaking process. DOT posts these 
comments, without edit, including any personal information the 
commenter provides, to www.regulations.gov, as described in the system 
of records notice (DOT/ALL-14 FDMS), which can be reviewed at 
www.dot.gov/privacy.

II. Background

    Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption 
for up to five years if it finds ``such exemption would likely achieve 
a level of safety that is equivalent to or greater than the level that 
would be achieved absent such exemption.'' The statute also allows the 
Agency to renew exemptions at the end of the five-year period. FMCSA 
grants exemptions from the FMCSRs for a two-year period to align with 
the maximum duration of a driver's medical certification.
    The physical qualification standard for drivers regarding epilepsy 
found in 49 CFR 391.41(b)(8) states that a person is physically 
qualified to drive a CMV if that person has no established medical 
history or clinical diagnosis of epilepsy or any other condition which 
is likely to cause the loss of consciousness or any loss of ability to 
control a CMV.
    In addition to the regulations, FMCSA has published advisory 
criteria to assist Medical Examiners in determining whether drivers 
with certain medical conditions are qualified to operate a CMV in 
interstate commerce (49 CFR part 391, APPENDIX A TO PART 391--MEDICAL 
ADVISORY CRITERIA, section H. Epilepsy: Sec.  391.41(b)(8), paragraphs 
3, 4, and 5).
    The 12 individuals listed in this notice have requested renewal of 
their exemptions from the epilepsy and seizure disorders prohibition in 
49 CFR 391.41(b)(8), in accordance with FMCSA procedures. Accordingly, 
FMCSA has evaluated these applications for renewal on their merits and 
decided to extend each exemption for a renewable two-year period.

III. Request for Comments

    Interested parties or organizations possessing information that 
would otherwise show that any, or all, of these drivers are not 
currently achieving the statutory level of safety should immediately 
notify FMCSA. The Agency will evaluate any adverse evidence submitted 
and, if safety is being compromised or if continuation of the exemption 
would not be consistent with the goals and objectives of 49 U.S.C. 
31136(e) and 31315, FMCSA will take immediate steps to revoke the 
exemption of a driver.

IV. Basis for Renewing Exemptions

    In accordance with 49 U.S.C. 31136(e) and 31315, each of the 12 
applicants has satisfied the renewal conditions for obtaining an 
exemption from the epilepsy and seizure disorders prohibition. The 12 
drivers in this notice remain in good standing with the Agency, have 
maintained their medical monitoring and have not exhibited any medical 
issues that would compromise their ability to safely operate a CMV 
during the previous two-year exemption period. In addition, for 
Commercial Driver's License (CDL) holders, the Commercial Driver's 
License Information System (CDLIS) and the Motor Carrier Management 
Information System (MCMIS) are searched for crash and violation data. 
For non-CDL holders, the Agency reviews the driving records from the 
State Driver's Licensing Agency (SDLA). These factors provide an 
adequate basis for predicting each driver's ability to continue to 
safely operate a CMV in interstate commerce. Therefore, FMCSA concludes 
that extending the exemption for each renewal applicant for a period of 
two years is likely to achieve a level of safety equal to that existing 
without the exemption.
    In accordance with 49 U.S.C. 31136(e) and 31315, the following 
groups of drivers received renewed exemptions in the month of September 
and are discussed below:
    As of September 9, 2018, and in accordance with 49 U.S.C. 31136(e) 
and 31315, the following eight individuals have satisfied the renewal 
conditions for obtaining an exemption from the epilepsy and seizure 
disorders prohibition in the FMCSRs for interstate CMV drivers:

Mark D. Anderson (NC)
Jeremy N. Bradford (AL)
Jeffrey B. Green (CA)
Stephen M. Harmon (WV)
Donald A. Horst (MD)
Kyle P. Loney (WA)
Leigh P. Mallory (VT)
Raymond H. VanDeMark (NJ)

    The drivers were included in docket number FMCSA-2015-0323. Their 
exemptions are applicable as of September 9, 2018, and will expire on 
September 9, 2020.
    As of September 16, 2018, and in accordance with 49 U.S.C. 31136(e) 
and 31315, the following four individuals have satisfied the renewal 
conditions for obtaining an exemption from the epilepsy and seizure 
disorders prohibition in the FMCSRs for interstate CMV drivers:

Lee H. Anderson (MA)
Gary A. Combs, Jr. (KY)
Roland K. Mezger (PA)
Robert Thomas, Jr. (NC)

    The drivers were included in docket number FMCSA-2014-0213. Their 
exemptions are applicable as of September 16, 2018, and will expire on 
September 16, 2020.

V. Conditions and Requirements

    The exemptions are extended subject to the following conditions: 
(1) Each driver must remain seizure-free and maintain a stable 
treatment during the two-year exemption period; (2) each driver must 
submit annual reports from their treating physicians attesting to the 
stability of treatment and that the driver has remained seizure-free; 
(3) each driver must undergo an annual medical examination by a 
certified Medical Examiner, as defined by 49 CFR 390.5; and (4) each 
driver must provide a copy

[[Page 58685]]

of the annual medical certification to the employer for retention in 
the driver's qualification file, or keep a copy of his/her driver's 
qualification file if he/she is self-employed. The driver must also 
have a copy of the exemption when driving, for presentation to a duly 
authorized Federal, State, or local enforcement official. The exemption 
will be rescinded if: (1) The person fails to comply with the terms and 
conditions of the exemption; (2) the exemption has resulted in a lower 
level of safety than was maintained before it was granted; or (3) 
continuation of the exemption would not be consistent with the goals 
and objectives of 49 U.S.C. 31136(e) and 31315.

VI. Preemption

    During the period the exemption is in effect, no State shall 
enforce any law or regulation that conflicts with this exemption with 
respect to a person operating under the exemption.

VII. Conclusion

    Based on its evaluation of the 12 exemption applications, FMCSA 
renews the exemptions of the aforementioned drivers from the epilepsy 
and seizure disorders prohibition in 49 CFR 391.41 (b)(8). In 
accordance with 49 U.S.C. 31136(e) and 31315, each exemption will be 
valid for two years unless revoked earlier by FMCSA.

    Issued on: November 9, 2018.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2018-25278 Filed 11-19-18; 8:45 am]
BILLING CODE 4910-EX-P

Federal Register / Vol. 83, No. 224 / Tuesday, November 20, 2018 / Notices 58683

research report ‘‘Implantable V. Conclusion dates stated in the discussions below
Cardioverter Defibrillators and the The Agency has determined that the and will expire on the dates stated in
Impact of a Shock in a Patient When available medical and scientific the discussions below. Comments must
Deployed.’’ Copies of the reports are literature and research provides be received on or before December 20,
included in the docket. insufficient data to enable the Agency to 2018.
FMCSA has published advisory conclude that granting these exemptions ADDRESSES: You may submit comments
criteria to assist medical examiners in would achieve a level of safety identified by the Federal Docket
determining whether drivers with equivalent to, or greater than, the level Management System (FDMS) Docket No.
certain medical conditions are qualified of safety maintained without the FMCSA–2014–0213; FMCSA–2015–
to operate a CMV in interstate exemption. Therefore, the following 0323 using any of the following
commerce. [Appendix A to Part 391— four applicants have been denied methods:
exemptions from the physical • Federal eRulemaking Portal: Go to
Medical Advisory Criteria, section D,
qualification standards in 49 CFR http://www.regulations.gov. Follow the
paragraph 4]. The advisory criteria for
391.41(b)(4): online instructions for submitting
49 CFR 391.41(b)(4) indicates that
David Christiansen (IL) comments.
coronary artery bypass surgery and • Mail: Docket Management Facility;
pacemaker implantation are remedial Christopher G. Harville (SC)
Terry W. Meredith (TN) U.S. Department of Transportation, 1200
procedures and thus, not medically New Jersey Avenue SE, West Building
disqualifying. Implantable cardioverter Grady C. Stone (GA)
Each applicant has, prior to this Ground Floor, Room W12–140,
defibrillators are disqualifying due to Washington, DC 20590–0001.
notice, received a letter of final
risk of syncope.
disposition regarding his/her exemption • Hand Delivery: West Building
III. Discussion of Comments request. Those decision letters fully Ground Floor, Room W12–140, 1200
outlined the basis for the denial and New Jersey Avenue SE, Washington,
FMCSA received no comments in this constitutes final action by the Agency. DC, between 9 a.m. and 5 p.m., ET,
proceeding. The list published today summarizes Monday through Friday, except Federal
the Agency’s recent denials as required Holidays.
IV. Basis for Exemption Determination • Fax: 1–202–493–2251.
under 49 U.S.C. 31315(b)(4). To avoid duplication, please use only
Under 49 U.S.C. 31136(e) and 31315, Issued on: November 9, 2018. one of these four methods. See the
FMCSA may grant an exemption if it Larry W. Minor, ‘‘Public Participation’’ portion of the
finds such an exemption would likely SUPPLEMENTARY INFORMATION section for
Associate Administrator for Policy.
achieve a level of safety that is instructions on submitting comments.
[FR Doc. 2018–25281 Filed 11–19–18; 8:45 am]
equivalent to, or greater then, the level
BILLING CODE 4910–EX–P FOR FURTHER INFORMATION CONTACT: Ms.
that would be achieved absent such an
Christine A. Hydock, Chief, Medical
exemption.
Programs Division, 202–366–4001,
The Agency’s decision regarding these DEPARTMENT OF TRANSPORTATION fmcsamedical@dot.gov, FMCSA,
exemption applications is based on an Department of Transportation, 1200
individualized assessment of each Federal Motor Carrier Safety New Jersey Avenue SE, Room W64–224,
applicant’s medical information Administration Washington, DC 20590–0001. Office
provided by the applicant, available [Docket No. FMCSA–2014–0213; FMCSA– hours are from 8:30 a.m. to 5 p.m., ET,
medical and scientific data concerning 2015–0323] Monday through Friday, except Federal
ICD’s, and public comments received. holidays. If you have questions
In the case of persons with ICDs, the Qualification of Drivers; Exemption regarding viewing or submitting
underlying condition for which the ICD Applications; Epilepsy and Seizure material to the docket, contact Docket
was implanted places the individual at Disorders Services, telephone (202) 366–9826.
high risk for syncope (a transient loss of AGENCY: Federal Motor Carrier Safety SUPPLEMENTARY INFORMATION:
consciousness) or other unpredictable Administration (FMCSA), DOT. I. Public Participation
events known to result in gradual or ACTION: Notice of renewal of
sudden incapacitation. ICDs may A. Submitting Comments
exemptions; request for comments.
discharge, which could result in loss of If you submit a comment, please
ability to safely control a CMV. See the SUMMARY: FMCSA announces its include the docket number for this
April 2007 Evidence Report on decision to renew exemptions for 12 notice (Docket Nos. FMCSA–2015–0323;
Cardiovascular Disease and Commercial individuals from the requirement in the FMCSA–2014–0213), indicate the
Motor vehicle Driver Safety, April Federal Motor Carrier Safety specific section of this document to
2007.1 A focused research report on Regulations (FMCSRs) that interstate which each comment applies, and
Implantable Cardioverter Defibrillators commercial motor vehicle (CMV) provide a reason for each suggestion or
and the Impact of a Shock on a Patient drivers have ‘‘no established medical recommendation. You may submit your
When Deployed completed for the history or clinical diagnosis of epilepsy comments and material online or by fax,
FMCSA December 2014 indicates that or any other condition which is likely mail, or hand delivery, but please use
the available scientific data on persons to cause loss of consciousness or any only one of these means. FMCSA
with ICDs and CMV driving does not loss of ability to control a CMV.’’ The recommends that you include your
support that persons with ICDs who exemptions enable these individuals name and a mailing address, an email
operate CMVs are able to meet an equal who have had one or more seizures and address, or a phone number in the body
or greater level of safety and upholds are taking anti-seizure medication to of your document so that FMCSA can
the findings of the April 2007 report. continue to operate CMVs in interstate contact you if there are questions
commerce. regarding your submission.
1 Now available at http://ntl.bts.gov/lib/30000/ DATES: Each group of renewed To submit your comment online, go to
30100/30123/Final_CVD_Evidence_Report_v2.pdf. exemptions were applicable on the http://www.regulations.gov, put the

VerDate Sep<11>2014 20:31 Nov 19, 2018 Jkt 247001 PO 00000 Frm 00160 Fmt 4703 Sfmt 4703 E:\FR\FM\20NON1.SGM 20NON1

Federal Register / Vol. 83, No. 224 / Tuesday, November 20, 2018 / Notices 58685

of the annual medical certification to with the identified best practices and the standing CSX train parked on the
the employer for retention in the that railroads take certain other actions siding.
driver’s qualification file, or keep a copy to ensure the safety of railroad In the draft Safety Advisory, FRA also
of his/her driver’s qualification file if operations during temporary signal noted the March 14, 2016 accident near
he/she is self-employed. The driver suspensions. FRA believes that actions Granger, Wyoming, which occurred
must also have a copy of the exemption consistent with this Safety Advisory when a Union Pacific Railroad (UP)
when driving, for presentation to a duly will reduce the risk of serious injury or freight train traveled from the main
authorized Federal, State, or local death both to railroad employees and track through a misaligned switch into
enforcement official. The exemption members of the public. a controlled siding and collided head-on
will be rescinded if: (1) The person fails FOR FURTHER INFORMATION CONTACT: with another UP freight train standing
to comply with the terms and Douglas Taylor, Staff Director, on the siding.
conditions of the exemption; (2) the Operating Practices, Office of Railroad Notably, both the Cayce and Granger
exemption has resulted in a lower level Safety, FRA, 1200 New Jersey Avenue accidents occurred while the operating
of safety than was maintained before it SE, Washington, DC 20590, telephone railroads were installing and testing
was granted; or (3) continuation of the (202) 493–6255; or Carolyn Hayward- positive train control (PTC) technology
exemption would not be consistent with Williams, Staff Director, Positive Train and while the railroads had temporarily
the goals and objectives of 49 U.S.C. Control/Signal & Train Control Division, suspended the signals in the accident
31136(e) and 31315. Office of Railroad Safety, FRA, 1200 areas to perform installation and testing
New Jersey Avenue SE, Washington, DC activities. In the Granger accident, while
VI. Preemption
20590, telephone (202) 493–6399. the signals were suspended, UP
During the period the exemption is in SUPPLEMENTARY INFORMATION: established absolute blocks intended to
effect, no State shall enforce any law or provide for the safe movement of trains
regulation that conflicts with this Background
through the area without signals. In the
exemption with respect to a person On April 23, 2018, FRA published a Cayce accident, the Amtrak train was
operating under the exemption. notice of a draft Safety Advisory in the operating on a track warrant and at the
VII. Conclusion Federal Register addressing railroad time of the accident, signal personnel
operations during temporary signal had stopped working for the day, yet the
Based on its evaluation of the 12 suspensions. 83 FR 17701. As stated in temporary signal suspension remained
exemption applications, FMCSA renews the draft Safety Advisory, a review of in place.
the exemptions of the aforementioned FRA’s accident/incident data shows that As explained in the draft Safety
drivers from the epilepsy and seizure overall, rail transportation, both Advisory, the National Transportation
disorders prohibition in 49 CFR 391.41 passenger and freight, is safe. However, Safety Board (NTSB) determined that
(b)(8). In accordance with 49 U.S.C. recent rail accidents occurring in areas the probable cause of the Granger
31136(e) and 31315, each exemption where a railroad has temporarily accident was the employee-in-charge
will be valid for two years unless suspended the signal system, typically incorrectly using information from a
revoked earlier by FMCSA. for purposes of maintenance, repair, or conversation with the train dispatcher
Issued on: November 9, 2018. installation of additional components as authorization to send a train into the
Larry W. Minor, for a new or existing system, area where the signal system suspension
Associate Administrator for Policy. demonstrate that rail operations during was in effect. The NTSB also found that
[FR Doc. 2018–25278 Filed 11–19–18; 8:45 am] signal suspensions present increased a contributing factor was the conductor
BILLING CODE 4910–EX–P
safety risks. In the draft Safety Advisory, pilot’s failure to check the switch
FRA specifically noted the February 4, position before authorizing the train to
2018 accident in Cayce, South Carolina, enter the area. Both FRA and the
DEPARTMENT OF TRANSPORTATION in which the engineer and conductor of NTSB’s investigations into the Cayce
National Railroad Passenger Corporation accident are ongoing and while neither
Federal Railroad Administration (Amtrak) Train P09103 were killed and agency has yet issued any formal
[Docket No. FRA–2018–0037; Notice No. 2;
115 passengers injured,1 when their findings, on February 13, 2018, the
Safety Advisory 2018–02] train collided head-on with a CSX NTSB issued a Safety Recommendation
Transportation, Inc. freight train (Train Report 2 to FRA regarding train
Safety Advisory Related to Temporary F77703). As noted in the draft Safety operations during signal suspensions. In
Signal Suspensions Advisory, while the cause of this its report, the NTSB recommended that
accident has not yet been determined, FRA issue an emergency order directing
AGENCY: Federal Railroad FRA’s preliminary investigation
Administration (FRA), Department of railroads to require train crews to
indicates that despite the CSX train approach switches at restricted speed
Transportation (DOT). crew reporting to the train dispatcher when signal suspensions are in effect
ACTION: Notice of Safety Advisory. that the switch was lined correctly, the and a switch has been reported relined
SUMMARY: FRA is issuing this Safety crew did not restore the main track for a main track (NTSB Safety
Advisory addressing railroad operations switch to its normal position as required Recommendation R–18–005). The NTSB
under temporary signal suspensions. by Federal regulation (Title 49 Code of further recommended that after the
This Safety Advisory recommends the Federal Regulations (CFR) 218.105) and switch position is verified, train crews
use of industry best practices when CSX’s own operating rules. The should be required to report to the
planning and implementing temporary misaligned switch diverted the next dispatcher that the switch is correctly
signal suspensions, including when train to traverse the location (the lined for the main track before
conducting rail operations under Amtrak train) into the siding and into
2 NTSB, Safety Recommendation Report: Train
temporary signal suspensions. This 1 Including 92 individuals who were transported Operation During Signal Suspension, Report No.
Safety Advisory also recommends that to medical facilities for treatment and 23 people RSR–18/01, Recommendation No. R–18–005 (Feb.
railroads develop and implement who received first aid at a triage area established 13, 2018), https://www.ntsb.gov/investigations/
procedures and practices consistent near the accident site. AccidentReports/Reports/RSR1801.pdf.

VerDate Sep<11>2014 20:31 Nov 19, 2018 Jkt 247001 PO 00000 Frm 00162 Fmt 4703 Sfmt 4703 E:\FR\FM\20NON1.SGM 20NON1

Document Created: 2018-11-20 07:59:15
Document Modified: 2018-11-20 07:59:15

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of renewal of exemptions; request for comments.
Dates		Each group of renewed exemptions were applicable on the dates stated in the discussions below and will expire on the dates stated in the discussions below. Comments must be received on or before December 20, 2018.
Contact		Ms. Christine A. Hydock, Chief, Medical Programs Division, 202-366-4001, [email protected], FMCSA, Department of Transportation, 1200 New Jersey Avenue SE, Room W64-224, Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m., ET, Monday through Friday, except Federal holidays. If you have questions regarding viewing or submitting material to the docket, contact Docket Services, telephone (202) 366-9826.
FR Citation		83 FR 58683

83 FR 58683 - Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders

DEPARTMENT OF TRANSPORTATIONFederal Motor Carrier Safety Administration

Federal Register Volume 83, Issue 224 (November 20, 2018)

DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration